Archive for the 'Medicaid' Category

Congressional Attention Focused on Independent Community Pharmacy and Patient Access to Care

By Michael Rule, Manager of Public Affairs and Grassroots Advocacy

NCPA’s 45th annual Legislative Conference wrapped up this week, and the timing could not have been more appropriate for independent community pharmacy. It was whirlwind week of legislative activity, to recap:

Continue reading ‘Congressional Attention Focused on Independent Community Pharmacy and Patient Access to Care’

Pharmacies Can Help Alleviate Drug Shortages, but Reimbursement Must Keep Up with Costs

By Kevin Schweers

With prescription drug shortages and pharmacy compounding hot topics, NCPA recently weighed in with Food and Drug Administration (FDA) officials on both fronts, in hopes of preserving patient access to essential medications from their independent community pharmacist. Continue reading ‘Pharmacies Can Help Alleviate Drug Shortages, but Reimbursement Must Keep Up with Costs’

NCPA Renews Concerns over Medicaid Generic Drug Reimbursement Changes

By Kevin Schweers

The U.S. Centers for Medicare & Medicaid Services (CMS) has published the 11th version of its draft federal upper limits (FULs) for Medicaid generic drug reimbursement, but the results are getting worse, not better, than preceding lists in terms of assuring continued patient access to prescription drugs and pharmacy services.

Continue reading ‘NCPA Renews Concerns over Medicaid Generic Drug Reimbursement Changes’

NCPA Urges Medicaid Officials to Fix Flawed Generic Drug Reimbursement Caps

By Kevin Schweers

The most recent batch proposed Medicaid caps on generic drug reimbursement—or federal upper limits (FULs)—would be “economically devastating” for independent community pharmacies, NCPA told federal officials in a new letter. Such cuts could endanger pharmacy access for Medicaid recipients as community pharmacies may be forced to drop out of the program or, in some cases, to close altogether.

Continue reading ‘NCPA Urges Medicaid Officials to Fix Flawed Generic Drug Reimbursement Caps’

NCPA Legislative Conference: Pharmacists Talk Medicare, Medicaid, Jobs

Between the Express Scripts-Medco merger, pharmacy crime, mail order in Tricare, and potential track and trace requirements in PDUFA, the 2012 NCPA Legislative Conference couldn’t be happening at a more relevant time, NCPA President Lonny Wilson, PD noted during the May 7th opening session.

Continue reading ‘NCPA Legislative Conference: Pharmacists Talk Medicare, Medicaid, Jobs’

New Limits on Medicaid Generic Drug Reimbursement Proposed; Same Inadequate Result

By Kevin Schweers

Earlier this month the Centers for Medicare & Medicaid Services issued its fifth set of proposed Medicaid federal upper limits (FULs) for generic drug reimbursement, but it’s no better than its four predecessors for patients and their community pharmacists, NCPA recently wrote to the agency.

Continue reading ‘New Limits on Medicaid Generic Drug Reimbursement Proposed; Same Inadequate Result’

Proposed Federal Limits Medicaid on Generic Drug Reimbursement Continue to Fall Short

By Kevin Schweers

Federal Medicaid officials published their fourth batch of draft federal upper limits (FULs) for generic drug reimbursement, but the proposed levels remain inadequate and, if implemented, could force many small independent pharmacies out of the Medicaid program, NCPA told the agency in a recent letter.

Continue reading ‘Proposed Federal Limits Medicaid on Generic Drug Reimbursement Continue to Fall Short’

Pharmacy Has Paid Their Fair Share

By John Coster

As the November 23 deadline approaches for the Joint Select Committee on Deficit Reduction to identify $1.2 trillion in savings over the next decade, its members are faced with an unenviable task. However, as these lawmakers seek new budget cuts, they should not overlook the fact that small business community pharmacies have given their fair share over the last several years.

Continue reading ‘Pharmacy Has Paid Their Fair Share’

Lewin Group/PBMs’ Medicaid Pharmacy Report Misses the Mark; Recommendations Threaten Patient Health and Access

By John Norton

In business or politics, endorsements from impartial sources can lend the credibility of third-party validation. Conversely, attempts to buy or manufacture third-party validation can fall flat. Such is the case with a recent white paper funded by the big pharmacy benefit managers (PBMs), apparently intended to further inflate their windfall profits, while harming Medicaid patients and local communities.

Continue reading ‘Lewin Group/PBMs’ Medicaid Pharmacy Report Misses the Mark; Recommendations Threaten Patient Health and Access’

A New Approach to Medicaid Reimbursement for Pharmacists

By Kevin Schweers

Community pharmacists and state Medicaid directors are watching a pair of state plan amendments Alabama is expected to propose soon to the U.S. Centers for Medicare and Medicaid Services. 

Continue reading ‘A New Approach to Medicaid Reimbursement for Pharmacists’


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search by Categories


Follow

Get every new post delivered to your Inbox.

Join 452 other followers